APA (7th ed.) Citation

Ł, B., M, S., A, G., I, S., N, R., A, Ś., . . . A, R. (2025). Molecular mechanisms restoring olaparib efficacy through ATR/CHK1 pathway inhibition in olaparib-resistant BRCA1/2MUT ovarian cancer models. Biochimica et biophysica acta. Molecular basis of disease, 1871(2), 167574. https://doi.org/10.1016/j.bbadis.2024.167574

Chicago Style (17th ed.) Citation

Ł, Biegała, Statkiewicz M, Gajek A, Szymczak-Pajor I, Rusetska N, Śliwińska A, Marczak A, Mikula M, and Rogalska A. "Molecular Mechanisms Restoring Olaparib Efficacy Through ATR/CHK1 Pathway Inhibition in Olaparib-resistant BRCA1/2MUT Ovarian Cancer Models." Biochimica Et Biophysica Acta. Molecular Basis of Disease 1871, no. 2 (2025): 167574. https://doi.org/10.1016/j.bbadis.2024.167574.

MLA (9th ed.) Citation

Ł, Biegała, et al. "Molecular Mechanisms Restoring Olaparib Efficacy Through ATR/CHK1 Pathway Inhibition in Olaparib-resistant BRCA1/2MUT Ovarian Cancer Models." Biochimica Et Biophysica Acta. Molecular Basis of Disease, vol. 1871, no. 2, 2025, p. 167574, https://doi.org/10.1016/j.bbadis.2024.167574.